Discontinued Operations (Details 2) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Feb. 27, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net sales			$ 544	$ 256	$ 1,527
Earnings (Loss) Before Tax		$ (6)	163	14	324
Income Tax Expense (Benefit)		26	63	21	31
Net Earnings (Loss)		(32)	100	(7)	293
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]
Pretax gain on sale of discontinued operations				2,837
Non-cash impact of tax expense associated with the gain on the sale of businesses				1,100
After Tax Gain		16		1,752
Developed markets branded generics pharmaceuticals business
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]
After Tax Gain	$ 1,600
Developed markets generics pharmaceuticals and animal health business
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net sales			544	256	1,527
Earnings (Loss) Before Tax		(6)	163	14	324
Income Tax Expense (Benefit)		(1)	58	11	68
Net Earnings (Loss)		(5)	105	3	256
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]
Pretax gain on sale of discontinued operations				2,837
Non-cash impact of tax expense associated with the gain on the sale of businesses				1,085
After Tax Gain				1,752
AbbVie
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Income Tax Expense (Benefit)		27	5	10	(37)
Net Earnings (Loss)		$ (27)	$ (5)	$ (10)	$ 37